Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Conversation: CML Highlights of EHA 2024 - Clinical overview

Andreas Hochhaus

Expert:

Professor Andreas Hochhaus
Director of the Department of Hematology and Medical Oncology
Jena University Hospital (Germany)

iCMLf Conversation: CML Highlights of ASH 2023 - Biological overview

Michael Deininger

Expert:

Professor Michael Deininger
Versiti Blood Research Institute, Milwaukee (USA)

iCMLf Conversation: CML Highlights of ASH 2023 - Clinical overview

Naranie

Expert:

Dr Naranie Shanmunagathan
Royal Adelaide Hospital and SA Pathology,
Adelaide (Australia)

iCMLf Conversation: Highlights of ESH-iCMLf 25th Annual John Goldman Conference on CML - Clinical overview

Jorge Cortes 2013

Expert:

Professor Jorge Cortes
Georgia Cancer Centre, Augusta (USA)

iCMLf Conversation: Highlights of ESH-iCMLf 25th Annual John Goldman Conference on CML- Biological overview incl. Q&A Session

Daniela Krause

Expert:

Professor Daniela Krause
Director of the Institute of Transfusion Medicine at the University of Mainz  (Germany)